MHEYE Ltd
Over the last three years, we have developed a novel device that is user-friendly and simple to use at home for relieving dry eye symptoms. A significant number of individuals experienced relief from their symptoms after using BMOIST for just a few months. Published clinical trials have demonstrated an effectiveness rate as high as 90%, which is significantly higher than other treatments. This development is led by Prof. Michael Belkin, who is listed among the top 100 ophthalmologists worldwide in the 2024.
An entrepreneur and designer with extensive experience, having completed dozens of projects.
Mr. Steli Loznen is the PRRC (Person Responsible for Regulatory Compliance) at the company. For many years he was the head of the medical device testing department at SII. Mr. Loznen is the author of the book Electrical Product Compliance and Safety Engineering.